Monday, 24 September 2018

Farxiga achieved a positive result in the Phase III DECLARE-TIMI 58 trial, a large cardiovascular outcomes trial in 17,000 patients with type-2 diabetes

submitted by /u/BSP_
[link] [comments]

from Health https://ift.tt/2IanI8z
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)